Emerging Tick-Borne Diseases and Blood Safety; Public Workshop

The Food and Drug Administration (FDA) is announcing a public workshop entitled ``Emerging Tick-Borne Diseases and Blood Safety.'' The purpose of the public workshop is to discuss tick-borne pathogens that continue to emerge as threats to blood safety, the effectiveness of current and potential mitigation strategies, and the general approach to decision making on blood safety interventions. The workshop has been planned in partnership with AABB; America's Blood Centers; National Heart, Lung, and Blood Institute, National Institutes of Health (NIH); the U.S. Department of Defense; and the U.S. Department of Health and Human Services. The workshop will include presentations and panel discussions by experts from academic institutions, industry, and government agencies.